Diagnostic dilemma in an adolescent boy: Hemophagocytic syndrome in association with kala azar

American Journal of the Medical Sciences

Volumn 334, Issue 2, 2007, Pages 139-141

  Celik, Umit ^a,b   Alabaz, Derya ^a   Alhan, Emre ^a   Bayram, Ibrahim ^a   Celik, Tamer ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Adolescent; Hemophagocytic syndrome; Visceral leishmaniasis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CEFEPIME; FERRITIN; FIBRINOGEN; HEMOGLOBIN; LIVER ENZYME; MEGLUMINE ANTIMONATE; TRIACYLGLYCEROL;

ADOLESCENT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SUBSTITUTION; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOFIBRINOGENEMIA; LABORATORY TEST; MACULOPAPULAR RASH; MALE; NEUTROPENIA; PANCYTOPENIA; PHYSICAL EXAMINATION; PLEURA EFFUSION; SEPTIC SHOCK; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; VESICULAR RASH; VISCERAL LEISHMANIASIS;

ADOLESCENT; HUMANS; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

EID: 34547906443     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31812e97f4     Document Type: Article

References (14)

1. Bhattacharya SK, Sur D, Karbwang J. Childhood visceral leishmaniasis. Indian J Med Res 2006;123:353-6.
2. Vilela RB, Bordin JO, Chiba AK, et al. RBC-associated IgG in patients with visceral leishmaniasis (kala-azar): a prospective analysis. Transfusion 2002;42:1442-7.
3. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders: World Health Organization, Committee on Histiocytic/Reticulum Cell Proliferations, Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157-66.
4. th edition). Philadelphia: Lippincott-Wilkins. 2006;768-85.
5. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993.
6. Risdall RJ, Brunning RD, Hernandez JI. Bacteria-associated hemophagocytic syndrome. Cancer 1994;54:2968.
7. Campo E, Condom E, Miro MJ, et al. Tuberculosis-associated hemophagocytic syndrome. Cancer 1986;58:2640.
8. Kocak N, Eren M, Yüce A, et al. Hemophagocytic syndrome associated with visceral leishmaniasis. Indian Pediatr 2004;41:605-7.
9. Tunc B, Ayata A. Hemophagocytic syndrome: a rare lifethreatening complication visceral leishmaniasis in a young boy. Pediatr Hematol Oncol 2001;18:531-6.
10. Marom D, Offer I, Tamry H, et al. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Pediatr Hematol Oncol 2000;18:65-70.
11. Kontopoulou T, Tsaousis G, Vaidakis E, et al. Hemophagocytic syndrome in association with visceral leishmaniasis. Am J Med 2002;113:439-40.
12. Kersten ST, Scott P. The role of innate immune responses in Th1 cell development following Leishmania major infection. J Leukocyte Biol 1995;57:515-22.
13. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis: the FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:129-33.
14. Kaito K, Kobayashi M, Katayama T, et al. Prognostic factors in hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997;59:247-53.